Evidence map›Paper›PMID 33116662›Full record

ArticleInfection and drug resistance2020

AmpR Increases the Virulence of Carbapenem-Resistant

Min Zhang, Jinyong Zhang, Jia Li, Xianglin Wu, Lihua Xiao, Xueyan Liu, Xiyao Yang, Liqi Yang, Quanming Zou, Wei Huang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Synergy of Plant Essential Oils in Antibiotic Therapy to CombatPharmaceuticals (Basel, Switzerland) · 2023
    Article
  2. Article
  3. Article
  4. FromMicroorganisms · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Min Zhang *Bacteriology & Antibacterial Resistance Surveillance Laboratory, Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong 518020, People's Republic of China.
Jinyong Zhang *National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, People's Republic of China.ORCID 0000-0001-9622-5834
Jia LiDepartment of Infection Control,Bengbu Third People's Hospital, Bengbu, Anhui, People's Republic of China.
Xianglin WuDepartment of Laboratory Medicine, University of Chinese Academy Sciences Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
Lihua XiaoDepartment of Laboratory Medicine, University of Chinese Academy Sciences Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
Xueyan LiuIntensive Care Unit, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong 518020, People's Republic of China.
Xiyao YangDepartment of Infection Control, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.
Liqi YangDepartment of Infection Control, Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.
Quanming ZouNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, People's Republic of China.
Wei HuangBacteriology & Antibacterial Resistance Surveillance Laboratory, Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong 518020, People's Republic of China.ORCID 0000-0002-8569-5184
Jinan University · CNAnhui Medical University · CNArmy Medical University · CNBengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-hypermucoviscous carbapenem-resistant

methodsFollowing a retrospective study of carbapenem-resistant

resultsThe subclone of sequence type 11 (ST11)

conclusionNon-hypermucoviscous ST11 carbapenem-resistant

Indexed as

capsule synthesiscarbapenem-resistantKlebsiella pneumoniavirulence

Identifiers

PMID33116662
PMCPMC7547782
OpenAlexW3091199101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.